⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

Official Title: A Phase I-II Study of BIBF 1120 and FOLFOX Compared to Bevacizumab and FOLFOX in First Line Metastatic Colorectal Cancer Patients

Study ID: NCT00904839

Conditions

Colorectal Neoplasms

Interventions

Study Description

Brief Summary: The primary objective of this study is to evaluate PFS rate at 9 months of BIBF 1120 in combination with mFolfox6 compared with mFolfox6 combined to bevacizumab in first line patients with metastatic colorectal cancer.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

1199.51.32002 Boehringer Ingelheim Investigational Site, Bonheiden, , Belgium

1199.51.32005 Boehringer Ingelheim Investigational Site, Bruxelles, , Belgium

1199.51.32006 Boehringer Ingelheim Investigational Site, Bruxelles, , Belgium

1199.51.32001 Boehringer Ingelheim Investigational Site, Leuven, , Belgium

1199.51.3306A Boehringer Ingelheim Investigational Site, Nice Cedex 2, , France

1199.51.3306B Boehringer Ingelheim Investigational Site, Nice Cedex 2, , France

1199.51.3306C Boehringer Ingelheim Investigational Site, Nice Cedex 2, , France

1199.51.3306D Boehringer Ingelheim Investigational Site, Nice Cedex 2, , France

1199.51.3301A Boehringer Ingelheim Investigational Site, Paris, , France

1199.51.3301B Boehringer Ingelheim Investigational Site, Paris, , France

1199.51.3301C Boehringer Ingelheim Investigational Site, Paris, , France

1199.51.3301D Boehringer Ingelheim Investigational Site, Paris, , France

1199.51.3307A Boehringer Ingelheim Investigational Site, Reims Cedex, , France

1199.51.3307B Boehringer Ingelheim Investigational Site, Reims Cedex, , France

1199.51.3307C Boehringer Ingelheim Investigational Site, Reims Cedex, , France

1199.51.3308B Boehringer Ingelheim Investigational Site, Saint Herblain, , France

1199.51.3308C Boehringer Ingelheim Investigational Site, Saint Herblain, , France

1199.51.3308A Boehringer Ingelheim Investigational Site, Saint-Herblain cedex, , France

1199.51.3308D Boehringer Ingelheim Investigational Site, Saint-Herblain cedex, , France

1199.51.3308E Boehringer Ingelheim Investigational Site, Saint-Herblain cedex, , France

1199.51.3305A Boehringer Ingelheim Investigational Site, Toulouse cedex 3, , France

1199.51.3305B Boehringer Ingelheim Investigational Site, Toulouse cedex 3, , France

1199.51.3305E Boehringer Ingelheim Investigational Site, Toulouse Cedex 3, , France

1199.51.3305C Boehringer Ingelheim Investigational Site, Toulouse Cedex, , France

1199.51.3305D Boehringer Ingelheim Investigational Site, Toulouse Cedex, , France

1199.51.3302A Boehringer Ingelheim Investigational Site, Villejuif Cedex, , France

1199.51.3302B Boehringer Ingelheim Investigational Site, Villejuif Cedex, , France

1199.51.3302C Boehringer Ingelheim Investigational Site, Villejuif Cedex, , France

1199.51.3302D Boehringer Ingelheim Investigational Site, Villejuif Cedex, , France

1199.51.3302E Boehringer Ingelheim Investigational Site, Villejuif Cedex, , France

1199.51.49001 Boehringer Ingelheim Investigational Site, Celle, , Germany

1199.51.49002 Boehringer Ingelheim Investigational Site, Dresden, , Germany

1199.51.49003 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau, , Germany

1199.51.49004 Boehringer Ingelheim Investigational Site, Halle/Saale, , Germany

1199.51.49006 Boehringer Ingelheim Investigational Site, Mainz, , Germany

1199.51.49008 Boehringer Ingelheim Investigational Site, Schwäbisch Hall, , Germany

1199.51.39002 Boehringer Ingelheim Investigational Site, Ancona, , Italy

1199.51.39001 Boehringer Ingelheim Investigational Site, Genova, , Italy

1199.51.39004 Boehringer Ingelheim Investigational Site, Macerata, , Italy

1199.51.39005 Boehringer Ingelheim Investigational Site, Reggio Emilia, , Italy

1199.51.39003 Boehringer Ingelheim Investigational Site, Udine, , Italy

1199.51.34006 Boehringer Ingelheim Investigational Site, Alicante, , Spain

1199.51.34005 Boehringer Ingelheim Investigational Site, Barakaldo, , Spain

1199.51.34001 Boehringer Ingelheim Investigational Site, Barcelona, , Spain

1199.51.34007 Boehringer Ingelheim Investigational Site, La Coruña, , Spain

1199.51.34003 Boehringer Ingelheim Investigational Site, Madrid, , Spain

1199.51.34004 Boehringer Ingelheim Investigational Site, Madrid, , Spain

Contact Details

Name: Boehringer Ingelheim

Affiliation: Boehringer Ingelheim

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: